Regional Distribution of the Neurovascular Devices Market

In 2024, the North American neurovascular devices market occupies a market share of 27.62%.

Trends in the U.S. Neurovascular Devices Market

The U.S. neurovascular devices market is experiencing significant growth, driven by the increasing cases of cerebrovascular diseases such as stroke, aneurysm, and arteriovenous malformations. The aging population and the rising prevalence of lifestyle-related conditions like hypertension and diabetes significantly promote the demand for neurovascular interventions. Technological advancements, including the development of minimally invasive devices such as flow diverters, stent retrievers, and embolization coils, have improved patient treatment outcomes and propelled market expansion. Support from regulatory bodies like the FDA has fostered innovation in this field by accelerating the approval of breakthrough devices. Collaborations between medical device companies and healthcare providers to develop new solutions have also contributed to the growth of the neurovascular devices market.

In 2024, the Canadian neurovascular devices market holds a significant share. The country's healthcare coverage and mandatory insurance system promote the adoption of advanced technologies. Industrialization in Quebec and Ontario is expected to have a positive impact on the market due to the entry of new market participants. Additionally, increased awareness and the focus on neurovascular research by organizations such as the Canadian Neurosciences Federation and the Canadian Neurovascular Health Association are expected to support future market growth.

Trends in the European Neurovascular Devices Market

The European neurovascular devices market is experiencing significant growth. The market is driven by the increasing aging population and rapid advancements in surgical reconstruction technologies. The growing adoption of technologically advanced devices and the rising number of cranio-maxillofacial (CMF) surgeries are expected to further promote market growth. The UK and Germany are major markets in Europe. However, in developing countries within Europe, the lack of supportive reimbursement policies hinders market growth during the forecast period.

The UK neurovascular devices market is likely to show significant growth due to the increased awareness of acute ischemic stroke treatments and the presence of several major companies in the market. According to NHS England, over 100,000 people suffer from stroke annually, and there are 1.3 million stroke survivors in the UK. Moreover, a study published on the UK Parliament website in January 2023 announced the government's intention to implement a major disease strategy in England. This strategy aims to address the major causes of disease and death nationwide, with a focus on cardiovascular diseases, including stroke.

The German neurovascular devices market is experiencing significant growth. The rising incidence of acute ischemic stroke has led to an increase in the number of mechanical thrombectomy procedures, and the high adoption rate of technologically advanced products are the main factors driving the growth of the German neurovascular devices market. The increase in mechanical thrombectomy procedures and the widespread adoption of advanced products are also other important factors expected to drive market growth in Germany.

Trends in the Asia-Pacific Neurovascular Devices Market

The neurovascular devices market in the Asia-Pacific region is rapidly growing, driven by the high prevalence of neurological disorders, rapid improvement in healthcare infrastructure, and availability of new products. Additionally, a large patient group suffering from cerebral aneurysms and strokes and the growing demand for advanced and cost-effective medical solutions are expected to create significant regional growth opportunities in the market.

The market of neurovascular devices in China is growing at a considerable rate, mainly due to the presence of numerous local and key enterprises in the market and the increasing number of stroke cases. For example, a study published in JAMA Network Open in March 2023 estimated the incidence and mortality rates of stroke in China. The study indicated that the overall stroke incidence for individuals aged 40 years and older is 500 cases per 100,000 person-years. The rising incidence of stroke in China is expected to drive the market's development in the coming years.